Neurodevelopment in infants with antenatal or early neonatal exposure to SARS-CoV-2

Sarah B Mulkey1, Meagan E Williams2, Nadia Jadeed2

  • 1Children's National Hospital, 111 Michigan Ave NW, Washington, DC 20010, United States; Department of Neurology, The George Washington University School of Medicine and Health Sciences, 2300 I St NW, Washington, DC 20037, United States; Department of Pediatrics, The George Washington University School of Medicine and Health Sciences, 2300 I St NW, Washington, DC 20037, United States.

Early Human Development
|November 19, 2022
PubMed

Insights

Infants exposed to SARS-CoV-2 in utero, particularly from symptomatic mothers, showed more frequent neurodevelopmental delays. Early screening is crucial for these infants to monitor and address potential delays.

Area of Science:

  • Pediatric Neurology
  • Developmental Pediatrics
  • Infectious Diseases

Background:

  • Prenatal and neonatal viral infections pose risks to infant brain development.
  • A specialized program at Children's National Hospital tracks infants with SARS-CoV-2 exposure.

Purpose of the Study:

  • To assess the neurodevelopmental impact of early SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) exposure in infants.
  • To identify specific risks associated with different exposure types (in utero vs. neonatal).

Main Methods:

  • Prospective observational study of 34 infants evaluated between March 2020 and November 2021.
  • Data collected included demographics, maternal health, SARS-CoV-2 status, and neonatal intensive care unit (NICU) records.
  • Infants underwent neurologic examinations and developmental screening using the Ages and Stages Questionnaire (ASQ).

Main Results:

  • Most infants (82%) had in utero exposure, with 16 from symptomatic mothers (IU-S) and 12 from asymptomatic mothers (IU-A).
  • IU-S infants exhibited more frequent abnormal neurologic exams and ASQ scores below cut-offs compared to IU-A and neonatally exposed infants.
  • Significant differences were observed in Fine Motor (P=.01) and Personal-Social (P=.02) domains for IU-S infants compared to IU-A.

Conclusions:

  • Early SARS-CoV-2 exposure, especially in utero to symptomatic mothers, may negatively affect infant neurodevelopment.
  • Preventing early-life infections through vaccination and precautions is vital for protecting against neurodevelopmental delays.
  • Infants with early SARS-CoV-2 exposure require ongoing neurodevelopmental screening and monitoring.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.6K
Neurulation01:30

Neurulation

Neurulation is the embryological process which forms the precursors of the central nervous system and occurs after gastrulation has established the three primary cell layers of the embryo: ectoderm, mesoderm, and endoderm. In humans, the majority of this system is formed via primary neurulation, in which the central portion of the ectoderm—originally appearing as a flat sheet of cells—folds upwards and inwards, sealing off to form a hollow neural tube. As development proceeds, the...
42.2K
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
415